Saltar al contenido
Merck

Angiotensin-converting enzyme 2 is an essential regulator of heart function.

Nature (2002-06-21)
Michael A Crackower, Renu Sarao, Gavin Y Oudit, Chana Yagil, Ivona Kozieradzki, Sam E Scanga, Antonio J Oliveira-dos-Santos, Joan da Costa, Liyong Zhang, York Pei, James Scholey, Carlos M Ferrario, Armen S Manoukian, Mark C Chappell, Peter H Backx, Yoram Yagil, Josef M Penninger
RESUMEN

Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.